【摘要】：目的：觀察驗方瀉白散加味治療小兒肺熱型便秘的臨床有效性及安全性,初步探討分析從肺論治小兒便秘的臨床實用性,為臨床從肺論治小兒便秘提供理論及數據支持,為臨床診療提供科學參考。方法：通過成都中醫(yī)藥大學附屬醫(yī)院兒科門診收集符合納入標準的患兒60例,分為治療組和對照組各30例,治療組予以驗方瀉白散加味口服,對照組予以中成藥麻仁丸口服。連續(xù)給藥2周后,觀察記錄兩組治療前后情況,收集研究數據進行匯總、整理,經SPSS17.0軟件處理,進行統(tǒng)計學描述和分析。結果：1、基線分析：兩組患兒在性別、年齡、病程以及主、次癥積分等方面無明顯差異(P0.05),具有可比性；2、組內對照：治療組與對照組治療前后自身組內主癥及主癥積分比較差異顯著(P0.01),次癥及次癥積分比較具有統(tǒng)計學差異(P0.05)；3、組問對照：兩組治療后組間比較主、次癥療效及疾病總療效具有顯著統(tǒng)計學差異(P0.05)；4、疾病總療效統(tǒng)計：治療組臨床治愈12例,顯效14例,有效3例,無效1例,愈顯率86.67%,總有效率96.67%；對照組臨床治愈4例,顯效11例,有效12例,無效3例,愈顯率50.00%,總有效率90.00%。結論：瀉白散加味治療小兒肺熱型便秘臨床療效顯著,且安全可靠。
[Abstract]:Objective: to observe the clinical efficacy and safety of Xiebai Powder in the treatment of infantile pulmonary heat type constipation, to explore the clinical practicability of treating infantile constipation from lung theory, and to provide theoretical and data support for clinical treatment of infantile constipation from lung theory. To provide scientific reference for clinical diagnosis and treatment. Methods: a total of 60 children were divided into treatment group (n = 30) and control group (n = 30) through pediatric outpatient clinic of affiliated Hospital of Chengdu University of traditional Chinese Medicine. The treatment group was treated with Xiebai Powder orally, and the control group with Chinese patent medicine Maren Pill. After 2 weeks of continuous administration, the two groups were observed and recorded before and after treatment, and the data were collected and sorted out. The data were described and analyzed statistically by SPSS17.0 software. Results: there were no significant differences between the two groups in sex, age, course of disease and scores of major and secondary symptoms (P0.05). 2, control group: before and after treatment between the treatment group and the control group, the scores of main symptoms and main symptoms were significantly different (P0.01), and the scores of secondary symptoms and secondary symptoms were significantly different (P0.05). There was significant difference in the curative effect of secondary symptom and total curative effect of disease (P0.05). The total curative effect of disease was statistically significant. In the treatment group, 12 cases were clinically cured, 14 cases were markedly effective, 3 cases were effective, 1 case was ineffective, the effective rate was 86.67%, and the total effective rate was 96.67%, while in the control group, 4 cases were clinically cured. There were 11 cases of remarkable effect, 12 cases of effective and 3 cases of failure. The effective rate was 50.000.The total effective rate was 90.00g. Conclusion: Xiebai Powder is safe and reliable in the treatment of infantile pulmonary heat constipation.
【學位授予單位】：成都中醫(yī)藥大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R272

【相似文獻】

相關期刊論文 前10條

1 趙暉;任耀全;;小議瀉白散[J];浙江中西醫(yī)結合雜志;2009年11期

2 趙暉;任耀全;;小議瀉白散[J];中國社區(qū)醫(yī)師(醫(yī)學專業(yè)半月刊);2009年24期

3 梁雨虹;;瀉白散的臨床應用探討[J];中國醫(yī)藥科學;2013年10期

4 吳錦發(fā);瀉白散加味治低熱[J];云南中醫(yī)中藥雜志;1996年01期

5 吳錦發(fā);瀉白散加味治低熱[J];中華養(yǎng)生保健;2004年20期

6 陳遐齡;瀉白散加味臨床運用舉隅[J];江西中醫(yī)藥;2003年08期

7 劉鳳琴;劉鳳麒;;瀉白散治療小兒熱退后咳嗽35例療效觀察[J];天津中醫(yī)藥;2008年01期

8 黃智芬;;參芪瀉白散[J];廣西中醫(yī)藥;2008年02期

9 呂學泰;瀉白散之擴用[J];安徽中醫(yī)學院學報;1986年01期

10 周繼剛;;瀉白散臨床運用舉隅[J];湖北中醫(yī)雜志;1988年04期

相關會議論文 前3條

1 孫彥敏;;瀉白散加活血化瘀藥治療發(fā)作期兒童哮喘[A];劉弼臣教授從醫(yī)六十五周年學術思想研討會暨中華中醫(yī)藥學會兒科分會與全國中醫(yī)藥高等教育學會兒科分會全國學術交流大會論文匯編[C];2004年

2 孫彥敏;白占青;侯靜宇;;瀉白散加味治療小兒咳嗽變異性哮喘120例療效觀察[A];第23屆全國中醫(yī)兒科學術研討會暨兒科名中醫(yī)講習班論文匯編[C];2006年

3 李春生;;加減瀉白散治療尋常性痤瘡68例[A];中華中醫(yī)藥學會皮膚科分會第四次學術年會;全國中醫(yī)、中西醫(yī)結合皮膚病診療新進展高級研修班論文集[C];2007年

相關重要報紙文章 前1條

1 重慶醫(yī)科大學中醫(yī)藥學院 洪蕾 楊艷梅;驅邪更在順勢[N];中國中醫(yī)藥報;2013年

相關碩士學位論文 前2條

1 周鴻栻;瀉白散加味治療小兒肺熱型便秘臨床療效觀察[D];成都中醫(yī)藥大學;2015年

2 林立;瀉白散HPLC譜效關系的研究[D];沈陽藥科大學;2009年

，

本文編號：2247117